查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1576799

消化道出血治療設備市場：按產品類型、治療類型和最終用戶分類 - 全球預測 2025-2030

Gastrointestinal Bleeding Treatment Devices Market by Product Type (Endoscopic Hemostatic Devices, Radiological Interventions), Treatment Type (Drug Therapy, Endoscopic Treatment, Surgical Treatment), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年消化道出血治療器材市值為5.3443億美元，預計2024年將達5.5943億美元，複合年成長率為5.26%，到2030年將達到7.6543億美元。

消化道出血治療設備市場由各種旨在診斷、管理和治療胃腸道出血的醫療技術定義。這個市場的需求根源在於潰瘍、靜脈曲張和癌症等胃腸道疾病的流行，這些疾病會導致嚴重的出血事件，因此需要高效且有效的介入設備。這些設備的應用範圍從內視鏡介入、開放性手術和微創手術到醫院、專科診所和門診手術中心。主要最終用途領域包括胃腸外科、急診科和專科門診。目前該市場受到胃腸道疾病發病率增加、全球人口老化以及微創手術技術進步等因素的推動。先進成像技術和人工智慧診斷的整合也處於行業成長的前沿，為企業利用技術聯盟和跨行業合作創造了機會。然而，市場面臨嚴格的監管要求、先進設備的高成本以及對熟練醫療保健專業人員的需求等挑戰。新興市場有限的醫療基礎設施也可能阻礙市場成長。該領域的創新者應專注於開發具有成本效益的攜帶式解決方案，並透過人工智慧和機器學習提高設備精度。具有巨大潛力的研究領域包括開發用於臨時干預的生物分解性材料和用於即時出血檢測的感測器技術。公司應考慮採取強力的研發舉措來滿足特定需求，例如不同臨床環境中的多功能性以及針對不同胃腸道疾病的設備分層的便利性。為了發現開拓的商機，必須了解區域市場的微妙動態，特別是衛生系統正在擴張的亞太和拉丁美洲。最終，透過培育與醫療保健提供者的夥伴關係並不斷響應監管變化，我們可以顯著加強我們在這個不斷發展的市場中的地位。

主要市場統計
基準年[2023] 53443萬美元
預測年份 [2024] 55943萬美元
預測年份 [2030] 76543萬美元
複合年成長率（%） 5.26%

市場動態：快速發展的消化道出血治療設備市場的關鍵市場洞察

消化道出血治療設備市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 政府對消化道出血治療的舉措和優惠報銷政策
    • 增加新興國家的醫療保健支出並改善醫療基礎設施
    • 擴大採用微創技術來治療消化道出血
    • 主要企業之間的聯盟與合作，促進產品開發與市場開拓
  • 市場限制因素
    • 先進消化道出血治療技術的開發與部署高成本
    • 一般醫療保健提供者對消化道出血治療進展的認知有限
  • 市場機會
    • 將先進的診斷成像技術整合到消化道出血治療設備中，以實現早期發現並提高準確性
    • 透過消化道出血治療設備製造商和醫療保健提供者之間的合作改善患者照護和治療結果
  • 市場挑戰
    • 複雜的患者需求需要開發高度專業的消化道出血治療解決方案

波特五力：駕馭消化道出血治療設備市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解消化道出血治療設備市場的外部影響

外部宏觀環境因素在塑造消化道出血治療設備市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解消化道出血治療器材市場競爭狀況

對消化道出血治療設備市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣消化道出血治療設備市場供應商的績效評估

FPNV 定位矩陣是評估消化道出血治療設備市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，描繪消化道出血治療設備市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對消化道出血治療設備市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 政府對消化道出血治療的舉措和優惠報銷政策
      • 新興國家的醫療保健成本增加並改善醫療保健基礎設施
      • 越來越多採用微創手術治療消化道出血
      • 主要參與者之間的合作和夥伴關係，以推動產品開發和市場成長
    • 抑制因素
      • 開發引進先進消化道出血治療技術高成本
      • 一般醫療保健專業人員對消化道出血治療進展的認知有限
    • 機會
      • 將先進的診斷影像技術融入消化道出血治療設備中，以實現早期發現並提高準確性
      • 消化道出血治療設備製造商和醫療保健提供者之間的合作，以改善患者照護和結果
    • 任務
      • 複雜的患者需求需要開發高度專業的消化道出血治療解決方案。
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章消化道出血治療設備市場：依產品類型

  • 內視鏡止血裝置
    • 止血夾
    • 注射裝置
    • 噴塗設備
    • 熱裝置
  • 放射治療
    • 栓塞劑
    • 硬化劑

第7章依治療類型分類的消化道出血治療設備市場

  • 藥物治療
    • Octreotide
    • 特利加壓素
  • 內視鏡治療
    • 注射療法
    • 機械處理
    • 熱凝固
  • 手術治療
    • 腹腔鏡手術
    • 開放性手術

第8章消化道出血治療設備市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院
    • 私立醫院
    • 公立醫院

第9章美洲消化道出血治療設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區消化道出血治療設備市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲/中東/非洲消化道出血治療器械市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-1A1A064C0286

The Gastrointestinal Bleeding Treatment Devices Market was valued at USD 534.43 million in 2023, expected to reach USD 559.43 million in 2024, and is projected to grow at a CAGR of 5.26%, to USD 765.43 million by 2030.

The market for gastrointestinal bleeding treatment devices is defined by a range of medical technologies aimed at diagnosing, managing, and treating bleeding in the gastrointestinal tract. This market's necessity is rooted in the prevalence of gastrointestinal conditions such as ulcers, varices, and cancers that can lead to critical bleeding incidents, necessitating efficient and effective intervention devices. Applications for these devices extend across endoscopic interventions, open surgeries, and minimally invasive procedures, catering to hospitals, specialized clinics, and ambulatory surgical centers. Key end-use domains include gastrointestinal surgery departments, emergency units, and specialized outpatient services. The market is currently driven by factors such as the growing incidence of gastrointestinal disorders, an aging global population, and advancements in minimally invasive surgical techniques. The integration of advanced imaging technologies and AI-driven diagnostics also spearhead industry growth, creating opportunities for companies to leverage technological partnerships and cross-industry collaborations. However, the market faces challenges including stringent regulatory requirements, high costs of advanced devices, and a need for skilled healthcare professionals. Market growth may also be hindered by limited healthcare infrastructure in developing regions. Innovators in this space should focus on developing cost-effective, portable solutions and enhancing device accuracy through AI and machine learning. Research areas with substantial potential include the development of biodegradable materials for temporary interventions and sensor technologies for real-time bleeding detection. Companies should consider engaging in robust R&D initiatives to address specific needs such as versatility in varied clinical settings and ease of device stratification for different gastrointestinal conditions. Understanding the nuanced dynamics of regional markets, particularly in Asia-Pacific and Latin America, where healthcare system expansion is ongoing, is essential for identifying untapped opportunities. Ultimately, fostering partnerships with healthcare providers and continuous adaptation to regulatory changes can significantly enhance positioning in this evolving market.

KEY MARKET STATISTICS
Base Year [2023] USD 534.43 million
Estimated Year [2024] USD 559.43 million
Forecast Year [2030] USD 765.43 million
CAGR (%) 5.26%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Gastrointestinal Bleeding Treatment Devices Market

The Gastrointestinal Bleeding Treatment Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Government initiatives and favorable reimbursement policies for gastrointestinal bleeding treatments
    • Rising healthcare expenditure and improving healthcare infrastructure in emerging economies
    • Increasing adoption of minimally invasive procedures for treating gastrointestinal bleeding
    • Collaborations and partnerships between key players driving product development and market growth
  • Market Restraints
    • High costs associated with the development and deployment of advanced gastrointestinal bleeding treatment technologies
    • Limited awareness among general healthcare providers about advancements in gastrointestinal bleeding treatments
  • Market Opportunities
    • Integration of advanced diagnostic imaging technologies in gastrointestinal bleeding treatment devices to improve early detection and precision
    • Collaborations between gastrointestinal bleeding treatment device manufacturers and healthcare providers to enhance patient care and treatment outcomes
  • Market Challenges
    • Complex patient needs necessitate the development of highly specialized gastrointestinal bleeding treatment solutions

Porter's Five Forces: A Strategic Tool for Navigating the Gastrointestinal Bleeding Treatment Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Gastrointestinal Bleeding Treatment Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Gastrointestinal Bleeding Treatment Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Gastrointestinal Bleeding Treatment Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Gastrointestinal Bleeding Treatment Devices Market

A detailed market share analysis in the Gastrointestinal Bleeding Treatment Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Gastrointestinal Bleeding Treatment Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Gastrointestinal Bleeding Treatment Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Gastrointestinal Bleeding Treatment Devices Market

A strategic analysis of the Gastrointestinal Bleeding Treatment Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Gastrointestinal Bleeding Treatment Devices Market, highlighting leading vendors and their innovative profiles. These include 3M, Abbott Laboratories, Boston Scientific, CONMED Corporation, Cook Medical, Erbe Elektromedizin GmbH, Fujifilm Holdings Corporation, Hoya Corporation, Intuitive Surgical, Johnson & Johnson, Karl Storz SE & Co. KG, Medtronic, Merit Medical Systems, Olympus, Pentax Medical, Smith & Nephew, Stryker Corporation, Teleflex Incorporated, Terumo Corporation, and Zimmer Biomet.

Market Segmentation & Coverage

This research report categorizes the Gastrointestinal Bleeding Treatment Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Endoscopic Hemostatic Devices and Radiological Interventions. The Endoscopic Hemostatic Devices is further studied across Hemostatic Clips, Injection Devices, Spray Devices, and Thermal Devices. The Radiological Interventions is further studied across Embolization Agents and Sclerosants.
  • Based on Treatment Type, market is studied across Drug Therapy, Endoscopic Treatment, and Surgical Treatment. The Drug Therapy is further studied across Octreotide and Terlipressin. The Endoscopic Treatment is further studied across Injection Therapy, Mechanical Therapy, and Thermal Coagulation. The Surgical Treatment is further studied across Laparoscopic Surgery and Open Surgery.
  • Based on End User, market is studied across Ambulatory Surgical Centers, Clinics, and Hospitals. The Hospitals is further studied across Private Hospitals and Public Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Government initiatives and favorable reimbursement policies for gastrointestinal bleeding treatments
      • 5.1.1.2. Rising healthcare expenditure and improving healthcare infrastructure in emerging economies
      • 5.1.1.3. Increasing adoption of minimally invasive procedures for treating gastrointestinal bleeding
      • 5.1.1.4. Collaborations and partnerships between key players driving product development and market growth
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with the development and deployment of advanced gastrointestinal bleeding treatment technologies
      • 5.1.2.2. Limited awareness among general healthcare providers about advancements in gastrointestinal bleeding treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of advanced diagnostic imaging technologies in gastrointestinal bleeding treatment devices to improve early detection and precision
      • 5.1.3.2. Collaborations between gastrointestinal bleeding treatment device manufacturers and healthcare providers to enhance patient care and treatment outcomes
    • 5.1.4. Challenges
      • 5.1.4.1. Complex patient needs necessitate the development of highly specialized gastrointestinal bleeding treatment solutions
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Gastrointestinal Bleeding Treatment Devices Market, by Product Type

  • 6.1. Introduction
  • 6.2. Endoscopic Hemostatic Devices
    • 6.2.1. Hemostatic Clips
    • 6.2.2. Injection Devices
    • 6.2.3. Spray Devices
    • 6.2.4. Thermal Devices
  • 6.3. Radiological Interventions
    • 6.3.1. Embolization Agents
    • 6.3.2. Sclerosants

7. Gastrointestinal Bleeding Treatment Devices Market, by Treatment Type

  • 7.1. Introduction
  • 7.2. Drug Therapy
    • 7.2.1. Octreotide
    • 7.2.2. Terlipressin
  • 7.3. Endoscopic Treatment
    • 7.3.1. Injection Therapy
    • 7.3.2. Mechanical Therapy
    • 7.3.3. Thermal Coagulation
  • 7.4. Surgical Treatment
    • 7.4.1. Laparoscopic Surgery
    • 7.4.2. Open Surgery

8. Gastrointestinal Bleeding Treatment Devices Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Clinics
  • 8.4. Hospitals
    • 8.4.1. Private Hospitals
    • 8.4.2. Public Hospitals

9. Americas Gastrointestinal Bleeding Treatment Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Gastrointestinal Bleeding Treatment Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Gastrointestinal Bleeding Treatment Devices Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M
  • 2. Abbott Laboratories
  • 3. Boston Scientific
  • 4. CONMED Corporation
  • 5. Cook Medical
  • 6. Erbe Elektromedizin GmbH
  • 7. Fujifilm Holdings Corporation
  • 8. Hoya Corporation
  • 9. Intuitive Surgical
  • 10. Johnson & Johnson
  • 11. Karl Storz SE & Co. KG
  • 12. Medtronic
  • 13. Merit Medical Systems
  • 14. Olympus
  • 15. Pentax Medical
  • 16. Smith & Nephew
  • 17. Stryker Corporation
  • 18. Teleflex Incorporated
  • 19. Terumo Corporation
  • 20. Zimmer Biomet

LIST OF FIGURES

  • FIGURE 1. GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HEMOSTATIC CLIPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SPRAY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY EMBOLIZATION AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SCLEROSANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY OCTREOTIDE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TERLIPRESSIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY INJECTION THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY MECHANICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY THERMAL COAGULATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY LAPAROSCOPIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. AUSTRALIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 114. CHINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. CHINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 116. CHINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. CHINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 120. CHINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 123. INDIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. INDIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 125. INDIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 126. INDIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. INDIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 129. INDIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 132. INDONESIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. INDONESIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 134. INDONESIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 135. INDONESIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. INDONESIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 141. JAPAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. JAPAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 143. JAPAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 144. JAPAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. JAPAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. JAPAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 150. MALAYSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. MALAYSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 152. MALAYSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 153. MALAYSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. MALAYSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 156. MALAYSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 157. MALAYSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. MALAYSIA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. PHILIPPINES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 161. PHILIPPINES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 162. PHILIPPINES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 164. PHILIPPINES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 165. PHILIPPINES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 166. PHILIPPINES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. PHILIPPINES GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 168. SINGAPORE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SINGAPORE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 170. SINGAPORE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 171. SINGAPORE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SINGAPORE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 173. SINGAPORE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 174. SINGAPORE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 175. SINGAPORE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. SINGAPORE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 177. SOUTH KOREA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SOUTH KOREA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 179. SOUTH KOREA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 180. SOUTH KOREA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. SOUTH KOREA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 182. SOUTH KOREA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 183. SOUTH KOREA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 184. SOUTH KOREA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 185. SOUTH KOREA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 186. TAIWAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. TAIWAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 188. TAIWAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 189. TAIWAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. TAIWAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 191. TAIWAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 192. TAIWAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 193. TAIWAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 194. TAIWAN GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 195. THAILAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. THAILAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 197. THAILAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 198. THAILAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. THAILAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 200. THAILAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 201. THAILAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 202. THAILAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 203. THAILAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 204. VIETNAM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. VIETNAM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 206. VIETNAM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 207. VIETNAM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. VIETNAM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 209. VIETNAM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 210. VIETNAM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 211. VIETNAM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 212. VIETNAM GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 223. DENMARK GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. DENMARK GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 225. DENMARK GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 226. DENMARK GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. DENMARK GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 228. DENMARK GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 229. DENMARK GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 230. DENMARK GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 231. DENMARK GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 232. EGYPT GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. EGYPT GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 234. EGYPT GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 235. EGYPT GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. EGYPT GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 237. EGYPT GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 238. EGYPT GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 239. EGYPT GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 240. EGYPT GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 241. FINLAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. FINLAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 243. FINLAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 244. FINLAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. FINLAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 246. FINLAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 247. FINLAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 248. FINLAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 249. FINLAND GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 250. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 252. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 253. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 255. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 256. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 257. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 258. FRANCE GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 259. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC HEMOSTATIC DEVICES, 2018-2030 (USD MILLION)
  • TABLE 261. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY RADIOLOGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 262. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
  • TABLE 264. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY ENDOSCOPIC TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 265. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY SURGICAL TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 266. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 267. GERMANY GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
  • TABLE 268. ISRAEL GASTROINTESTINAL BLEEDING TREATMENT DEVICES MARKET SIZE, BY PRODUC